A two-stage design for comparative clinical trials: the heteroscedastic solution
From MaRDI portal
(Redirected from Publication:721618)
Recommendations
- Two-stage selection and testing designs for comparative clinical trials
- A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials
- A Two-Stage Selection and Testing Design for Comparing Several Normal Means with a Standard
- A Two-Stage Selection and Testing Design for Comparing Several Normal Means with a Standard: The Case of Common, Known Variance
- A selection and testing procedure for comparing several experimental treatments with a control
Cites work
- scientific article; zbMATH DE number 3913510 (Why is no real title available?)
- scientific article; zbMATH DE number 3527652 (Why is no real title available?)
- scientific article; zbMATH DE number 3624609 (Why is no real title available?)
- scientific article; zbMATH DE number 3089535 (Why is no real title available?)
- A Stein-Type Two-Sample Procedure for Comparing Normal Means
- A Two-Sample Test for a Linear Hypothesis Whose Power is Independent of the Variance
- A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials
- Bayesian adaptive methods for clinical trials
- On the Non-Existence of Tests of "Student's" Hypothesis Having Power Functions Independent of $\sigma$
- Some Fixed-Sample Ranking and Selection Problems
- The statistical sleuth. A course in methods of data analysis
- Two-stage selection and testing designs for comparative clinical trials
Cited in
(7)- A selection and testing procedure for comparing several experimental treatments with a control
- A multiple three-decision procedures for comparing several treatments with a control under heteroscedasticity
- Two-sample two-stage and purely sequential methodologies for tests of hypotheses with applications: comparing normal means when the two variances are unknown and unequal
- A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials
- Two-stage selection and testing designs for comparative clinical trials
- Two-Stage Designs with Additional Futility Tests for Phase II Clinical Trials with Heterogeneous Patient Populations
- A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity
This page was built for publication: A two-stage design for comparative clinical trials: the heteroscedastic solution
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q721618)